{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:17:48Z","timestamp":1792678668823,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:00:00Z","timestamp":1517616000000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["OC130046"],"award-info":[{"award-number":["OC130046"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"NCCIH","doi-asserted-by":"publisher","award":["T32 AT007533"],"award-info":[{"award-number":["T32 AT007533"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.canlet.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T04:48:43Z","timestamp":1484887723000},"page":"114-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling"],"prefix":"10.1016","volume":"391","author":[{"given":"Matthew","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.01.011_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016, CA","volume":"66","author":"Siegel","year":"2015","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.canlet.2017.01.011_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2017.01.011_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib5","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1541-7786.MCR-16-0097","article-title":"DNA methylome analyses implicate fallopian tube epithelia as the origin for high-grade serous ovarian cancer","volume":"14","author":"Klinkebiel","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.01.011_bib8","doi-asserted-by":"crossref","first-page":"20500","DOI":"10.18632\/oncotarget.3985","article-title":"Tumorigenesis and peritoneal colonization from fallopian tube epithelium","volume":"21","author":"Eddie","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.01.011_bib9","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29528","article-title":"Mutant p53 expression in fallopian tube epithelium drives cell migration","volume":"137","author":"Quartuccio","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2017.01.011_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A\u00a0genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2017.01.011_bib12","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.canlet.2017.01.011_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","article-title":"New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination","volume":"175","author":"Coffman","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.canlet.2017.01.011_bib15","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/srep06116","article-title":"Ovulation and extra-ovarian origin of ovarian cancer","volume":"4","author":"Yang-Hartwich","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2017.01.011_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tem.2005.01.003","article-title":"Antagonists of activin signaling: mechanisms and potential biological applications","volume":"16","author":"Harrison","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2017.01.011_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers7010070","article-title":"Intertwining of activin A and TGF\u03b2 signaling: dual roles in cancer progression and cancer cell invasion","volume":"7","author":"Loomans","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2017.01.011_bib18","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","article-title":"Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion","volume":"67","author":"Galliher","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cardiores.2005.11.007","article-title":"A\u00a0direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy","volume":"69","author":"Watkins","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib20","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1210\/en.2005-0457","article-title":"Transforming growth factor \u03b2-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone \u03b2-subunit expression","volume":"146","author":"Safwat","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2017.01.011_bib21","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1074\/jbc.M413223200","article-title":"Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase","volume":"280","author":"Yi","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.01.011_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200611146","article-title":"Cell size and invasion in TGF-\u03b2\u2013induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway","volume":"178","author":"Lamouille","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.canlet.2017.01.011_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1095\/biolreprod.102.012005","article-title":"Activin signaling pathways in ovine pituitary and L\u03b2T2 gonadotrope cells","volume":"68","author":"Dupont","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.canlet.2017.01.011_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/MCB.25.1.60-65.2005","article-title":"MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration","volume":"25","author":"Zhang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2017.01.011_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-10-67","article-title":"Differential roles of Smad2 and Smad3 in the regulation of TGF-\u03b21-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1","volume":"10","author":"Ungefroren","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib26","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","volume":"22","author":"Hoda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.01.011_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.49.3.409","article-title":"Overexpression of activin A in stage IV colorectal cancer","volume":"49","author":"Wildi","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2017.01.011_bib28","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/npjbcancer.2015.7","article-title":"Activin-A signaling promotes epithelial\u2013mesenchymal transition, invasion, and metastatic growth of breast cancer","volume":"1","author":"Bashir","year":"2015","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.1993.tb43850.x","article-title":"Inhibin, activin, and follistatin. Potential roles in ovarian physiology","volume":"687","author":"Hillier","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2017.01.011_bib30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2005.11.058","article-title":"Follicular fluid levels of inhibin A, inhibin B, and activin A levels reflect changes in follicle size but are not independent markers of the oocyte's ability to fertilize","volume":"85","author":"Wen","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.canlet.2017.01.011_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/360313a0","article-title":"Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice","volume":"360","author":"Matzuk","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.01.011_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12943-015-0433-y","article-title":"Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-\u03b2 and Activin-A","volume":"14","author":"Basu","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib33","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1210\/en.2007-1584","article-title":"The role of activin A and Akt\/GSK signaling in ovarian tumor biology","volume":"149","author":"Do","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2017.01.011_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1541-7786.50.3.1","article-title":"Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells","volume":"3","author":"Steller","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0090-8258(90)90008-9","article-title":"Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma","volume":"38","author":"Wong","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib36","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2017.01.011_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1210\/endo.141.3.7361","article-title":"Activin A-Induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins","volume":"141","author":"Chen","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2017.01.011_bib38","doi-asserted-by":"crossref","first-page":"e65067","DOI":"10.1371\/journal.pone.0065067","article-title":"Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas","volume":"8","author":"Quartuccio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.01.011_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-016-0213-3","article-title":"Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators","volume":"9","author":"Moyle-Heyrman","year":"2016","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.01.011_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6601603","article-title":"Predicting biomarkers for ovarian cancer using gene-expression microarrays","volume":"90","author":"Adib","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1349-7006.2009.01204.x","article-title":"Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis","volume":"100","author":"Yoshihara","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2017.01.011_bib44","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-05-3694","article-title":"Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas","volume":"66","author":"Hendrix","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib45","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive deescent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib46","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.01.011_bib47","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.01.011_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1476-4598-13-241","article-title":"OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets","volume":"13","author":"Madden","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib49","doi-asserted-by":"crossref","first-page":"e89553","DOI":"10.1371\/journal.pone.0089553","article-title":"Mutation or loss of p53 differentially modifies TGF\u03b2 action in ovarian cancer","volume":"9","author":"\u00d3 hAinmhire","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2017.01.011_bib50","first-page":"2125","article-title":"The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium","volume":"86","author":"Choi","year":"2001","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2017.01.011_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/wsbm.110","article-title":"Signaling pathways that control cell migration: models and analysis","volume":"3","author":"Welf","year":"2011","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.canlet.2017.01.011_bib52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In\u00a0vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"Mitra","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib53","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2017.01.011_bib54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2017.01.011_bib55","first-page":"703","article-title":"Determinants of ovarian cancer risk. I. reproductive experiences and family history","volume":"71","author":"Cramer","year":"1983","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.01.011_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humrep\/13.3.656","article-title":"Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy","volume":"13","author":"Fried","year":"1998","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.canlet.2017.01.011_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30233","article-title":"The TGF\u03b2 pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels","author":"Alsina-Sanchis","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/ERC-15-0383","article-title":"TGF\u03b2 signaling regulates epithelial\u2013mesenchymal plasticity in ovarian cancer ascites-derived spheroids","volume":"23","author":"Rafehi","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2017.01.011_bib59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2017.01.011_bib60","first-page":"2014","article-title":"Estimating cancer latency times using a weibull model, estimating cancer latency times using a Weibull model","volume":"2014","author":"Nadler","year":"2014","journal-title":"Adv. Epidemiol. Adv. Epidemiol."},{"key":"10.1016\/j.canlet.2017.01.011_bib61","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1471-0528.2000.tb11102.x","article-title":"Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma","volume":"107","author":"Menon","year":"2000","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.canlet.2017.01.011_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1999.5417","article-title":"Secretion of activin A in recurrent epithelial ovarian carcinoma","volume":"74","author":"Lambert-Messerlian","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib63","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.30.1_supplement.126.7","article-title":"Secretory factors produced by stromal cultures of human omental adipose tissue inhibit adipose differentiation","volume":"30","author":"Pickering","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2017.01.011_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/onc.2012.536","article-title":"Interaction with colon cancer cells hyperactivates TGF-\u03b2 signaling in cancer-associated fibroblasts","volume":"33","author":"Hawinkels","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.01.011_bib65","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.oraloncology.2011.06.011","article-title":"Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A","volume":"47","author":"Sobral","year":"2011","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2017.01.011_bib66","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1021\/acs.jmedchem.5b00753","article-title":"Virtual high-throughput screening to identify novel activin antagonists","volume":"58","author":"Zhu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.canlet.2017.01.011_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ar.a.10090","article-title":"Smad 3 regulates proliferation of the mouse ovarian surface epithelium","volume":"273A","author":"Symonds","year":"2003","journal-title":"Anat. Rec. Part A"},{"key":"10.1016\/j.canlet.2017.01.011_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2009.05.010","article-title":"Activin is a potent growth suppressor of epithelial ovarian cancer cells","volume":"285","author":"Ramachandran","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.01.011_bib69","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"T.C.G.A.R. Network","year":"2011","journal-title":"Nature"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517300344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517300344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:37:46Z","timestamp":1759592266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517300344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":69,"alternative-id":["S0304383517300344"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.01.011","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}